The drug is being marketed in the United States under the brand name Linzess. It was approved by the Food and Drug Administration earlier this year as a treatment for adults suffering from irritable bowel syndrome with constipation. Linzess is a trade name for linaclotide.
Around the Region
Ironwood drug now available in US
You've reached the limit of 10 free articles a month
Stay informed with unlimited access to Boston’s trusted news source.
- High-quality journalism from the region’s largest newsroom
- Convenient access across all of your devices
- Today’s Headlines daily newsletter
- Subscriber-only access to exclusive offers, events, contests, eBooks, and more
- Less than $1 a week